Bioprosthesis valve replacement in dogs with congenital tricuspid valve dysplasia: Technique and outcome

Assessment of a portable prothrombin time analyzer (CoaguChek‐XS) in dogs

“…The CoaguChek-XS had a higher sensitivity, but lower specificity compared to the SCA-2000, and a lower correlation to reference method compared to the Abaxis (r = 0.35 versus 0.578). 11,12 Routine oral anti-coagulant treatment is uncommonly practiced in dogs, although in certain cases (eg, treatment for aortic thromboembolism 21 and following heart valve replacement surgery 14,15 ) long-term warfarin therapy may be indicated in dogs. In such instances, home PT monitoring using the device may be considered.…”

Outcome of bioprosthetic valve replacement in dogs with tricuspid valve dysplasia

“…Similar to Arai et al’s description (Arai et al . ), tricuspid valve replacement was undertaken in dogs that had severe tricuspid valve incompetence associated with right heart failure and whose owners fully accepted the risks associated with this treatment, along with the associated financial obligations. Written client consent was obtained from all owners.…”

“…The technique for tricuspid valve replacement has been previously reported by Arai et al . (). The protocols for anaesthesia and cardiopulmonary bypass used in our study have also been reported previously (Orton et al .…”

“…In that study, dogs were considered candidates for tricuspid valve replacement if they had severe tricuspid valve regurgitation associated with signs of cardiac compromise such as severe exercise intolerance and ascites, and required ongoing medical therapy (Arai et al . ). Ten of the dogs survived surgery with a further two euthanased at 10 and 13 months postoperatively because of inflammatory pannus formation and consequent failure of the prosthesis.…”

Surgical Interventions of Common Congenital Heart Defects in Dogs: A Comprehensive Review

“…Diuretics, vasodilators, digoxin, and an angiotensin converting enzyme inhibitor may also be indicated. Arai et al [69] reported good intermediate-term outcomes in dogs with tricuspid vavle dysplagia undergoing tricuspid valve replacement with a bioprosthesis under cardiopulmonary bypass. Ten of the 12 (83.3%) dogs survived surgery and were discharged.…”